Literature DB >> 2584000

Low brain magnesium in migraine.

N M Ramadan, H Halvorson, A Vande-Linde, S R Levine, J A Helpern, K M Welch.   

Abstract

Brain magnesium was measured in migraine patients and control subjects using in vivo 31-Phosphorus Nuclear Magnetic Resonance Spectroscopy. pMg and pH were calculated from the chemical shifts between Pi, PCr and ATP signals. Magnesium levels were low during a migraine attack without changes in pH. We hypothesize that low brain magnesium is an important factor in the mechanism of the migraine attack.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2584000     DOI: 10.1111/j.1526-4610.1989.hed2909590.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  18 in total

Review 1.  Why all migraine patients should be treated with magnesium.

Authors:  Alexander Mauskop; Jasmine Varughese
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

Review 2.  Pharmacological targeting of spreading depression in migraine.

Authors:  Katharina Eikermann-Haerter; Anil Can; Cenk Ayata
Journal:  Expert Rev Neurother       Date:  2012-03       Impact factor: 4.618

3.  Nutraceuticals in Acute and Prophylactic Treatment of Migraine.

Authors:  Oved Daniel; Alexander Mauskop
Journal:  Curr Treat Options Neurol       Date:  2016-04       Impact factor: 3.598

Review 4.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

Review 5.  Advanced In Vivo Heteronuclear MRS Approaches for Studying Brain Bioenergetics Driven by Mitochondria.

Authors:  Xiao-Hong Zhu; Fei Du; Nanyin Zhang; Yi Zhang; Hao Lei; Xiaoliang Zhang; Hongyan Qiao; Kamil Ugurbil; Wei Chen
Journal:  Methods Mol Biol       Date:  2009

Review 6.  New and emerging prophylactic agents for migraine.

Authors:  Abouch V Krymchantowski; Marcelo E Bigal; Pedro F Moreira
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Intravenous magnesium as acute treatment for headaches: a pediatric case series.

Authors:  Emily Gertsch; Sheila Loharuka; Kristine Wolter-Warmerdam; Suhong Tong; Allison Kempe; Sita Kedia
Journal:  J Emerg Med       Date:  2013-10-29       Impact factor: 1.484

Review 8.  Structural and Functional Brain Changes in Migraine.

Authors:  Sait Ashina; Enrico Bentivegna; Paolo Martelletti; Katharina Eikermann-Haerter
Journal:  Pain Ther       Date:  2021-02-16

Review 9.  Use of Nutraceutical Ingredient Combinations in the Management of Tension-Type Headaches with or without Sleep Disorders.

Authors:  Paolo Curatolo; Romina Moavero
Journal:  Nutrients       Date:  2021-05-13       Impact factor: 5.717

Review 10.  The Role of Metabolism in Migraine Pathophysiology and Susceptibility.

Authors:  Olivia Grech; Susan P Mollan; Benjamin R Wakerley; Daniel Fulton; Gareth G Lavery; Alexandra J Sinclair
Journal:  Life (Basel)       Date:  2021-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.